When natural proteins are used in pharmaceutical products, they often need to be engineered to obtain improved functional and/or structural properties. Protein engineering helps develop effective protein therapeutics with improved affinity, pharmacokinetics, pharmacodynamics, immunogenicity, and productivity. As a one-stop protein engineering solution provider, CD Formulation can help customize and optimize your biotherapeutic lead candidates. Our protein engineers will provide you with the best combination of computer tools and expertise to potentially improve the structure, activity, and manufacturing properties of your drug candidates.
Protein engineering is the process of designing, modifying, and optimizing proteins to achieve specific functions or improve their performance. It combines principles from disciplines such as biochemistry, molecular biology, computational biology, and physics to manipulate proteins at the molecular level. The main goal of protein engineering is to identify specific changes in amino acid sequences and alter such sequences to obtain desired functional properties. Typically, this is achieved by using directed evolution techniques to generate a large number of random mutations in proteins and using appropriate screening systems to select improved variants.
Fig. 1 Protein engineering approach. (Sarah Oluwatobia O, et al., 2023)
As a high-quality service provider focusing on therapeutic protein production and engineering, CD Formulation is committed to providing advanced protein engineering services to assist you in the modification and optimization of your biotherapeutic lead drug candidates. Our team of experienced scientists and engineers can support the entire process from protein design to expression and purification.
We combine decades of experience in protein engineering with the latest technologies and methodologies to tailor solutions for your project. In addition, we provide protein analysis services for your specific project. We perform a range of routine protein analyses at all project stages to ensure protein identity, purity, structural and conformational integrity, and activity.
Our therapeutic protein engineering services include but are not limited to:
Our team uses the most advanced DNA synthesis technology to provide efficient polymerase chain reaction (PCR) protein mutagenesis services, as well as comprehensive upstream and downstream services, including template DNA sequencing, gene synthesis, expression vector construction, and protein expression and purification.
Protein modification and labeling have been important tools for creating therapeutic proteins and generating novel protein structures, involving adding or changing chemical groups after protein synthesis, or covalently attaching molecules such as biotin, fluorophores, enzymes, and radioisotopes to specific sites of target proteins. We offer a wide range of protein modification and labeling services to meet the research needs of different customers.
Constructing a protein mutation library is a key step to increase protein production, improve function, or study structure-function relationships, which can generate mutant proteins with improved or new properties. With strong expertise in high-throughput gene synthesis and site-directed mutagenesis, we are able to provide a variety of strategies, including gene synthesis, error-prone PCR, degenerate codon utilization, and DNA shuffling, to create your diverse protein mutation library to accelerate your project.
At CD Formulation, we specialize in custom protein engineering and advanced protein production. With our advanced protein development and production technology platforms, we are able to meet your specific needs. Our protein engineering expertise creates a variety of protein types, including but not limited to:
Downstream support services for therapeutic protein engineering include a range of processes and methods designed to refine, purify and characterize proteins with therapeutic applications. These services are critical to ensuring that therapeutic proteins meet the necessary quality, safety and efficacy standards before use in clinical settings or large-scale production.
We offer customizable downstream support services to help you through the entire project lifecycle, ensuring that the protein product is suitable for your downstream application.
Our downstream support services include:
Published Data
Technology: Protein Engineering
Journal: Cell Chem Biol.
IF: 6.6
Published: 2022
Results:
The authors investigated how protein engineering could be used to engineer IL-37 from a labile cytokine into an anti-inflammatory molecule with excellent therapeutic similarities. IL-37 was engineered into an Fc fusion protein by employing site-directed mutagenesis and adding unnatural disulfide bonds. The results showed that this method greatly improved stability and significantly improved pharmacokinetics (PK) while maintaining cytokine activity.
Fig. 2 Engineering an IL-37-Fc fusion with an improved therapeutic likeness. (Bujotzek A, et al., 2022)
At CD Formulation, our comprehensive approach encompasses every stage of protein production and engineering, ensuring that your lead drug candidates are optimized for maximum efficacy and safety. Please don't hesitate to contact us if you are interested in our services. We look forward to cooperating with you.
References